ARCkriterierne

ARCkriterierne, also known as the ARC criteria, are a set of guidelines used to assess the quality of randomized controlled trials (RCTs). They were developed by the Cochrane Collaboration to help researchers and clinicians evaluate the reliability and validity of RCTs. The criteria are divided into three main categories: allocation concealment, blinding, and attrition.

Allocation concealment refers to the process of ensuring that participants are randomly assigned to different groups without any bias. This is crucial to prevent selection bias, where participants in one group may differ systematically from those in another. The ARC criteria specify that the method of randomization should be adequately described and that the sequence of random allocations should be concealed until after the trial has been completed.

Blinding, or masking, involves ensuring that participants and researchers are unaware of the group assignments. This helps to minimize bias in the interpretation of results. The ARC criteria require that the methods used to blind participants and researchers should be described, and that the success of blinding should be assessed.

Attrition refers to the loss of participants during the course of the trial. The ARC criteria emphasize the importance of reporting the reasons for attrition and the potential impact on the results. This helps to ensure that the findings of the trial are not distorted by the loss of participants.

The ARC criteria are widely used in the medical and health sciences to assess the quality of RCTs. They provide a standardized framework for evaluating the reliability and validity of trials, which can help to improve the quality of evidence-based medicine. However, it is important to note that the ARC criteria are not a substitute for critical appraisal of individual trials, and should be used in conjunction with other methods of assessing trial quality.